{"product_id":"tesa-ipa-blend","title":"Tesamorelin + Ipamorelin Blend","description":"\u003cp dir=\"auto\"\u003e\u003cstrong\u003eTesamorelin + Ipamorelin Blend\u003c\/strong\u003e (also called \u003cstrong\u003eTesa\/Ipa\u003c\/strong\u003e or \u003cstrong\u003eTesamorelin\/Ipamorelin stack\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic peptide combination\u003c\/strong\u003e pairing \u003cstrong\u003eTesamorelin\u003c\/strong\u003e (a stabilized GHRH analog) with \u003cstrong\u003eIpamorelin\u003c\/strong\u003e (a selective ghrelin-receptor \/ GHS-R1a agonist). This research formulation is studied for synergistic stimulation of \u003cstrong\u003eendogenous pulsatile growth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) release and subsequent \u003cstrong\u003eIGF-1\u003c\/strong\u003e elevation, while aiming to keep off-target hormonal effects relatively low.\u003c\/p\u003e\n\u003cp dir=\"auto\"\u003eTesamorelin provides prolonged GHRH-receptor activation and is particularly associated in research with visceral-fat and metabolic endpoints. Ipamorelin adds selective GHS-R1a stimulation that can increase GH pulse amplitude\/frequency with minimal effects on cortisol and prolactin in preclinical models. Together they are used to investigate combined GHRH + GHS signaling, body-composition change, tissue repair, and age-related GH-axis decline. As a research-grade compound, this blend is intended exclusively for in vitro and animal studies.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic GH \/ IGF-1 Release\u003c\/strong\u003e — Combination studies examine supra-additive pulsatile GH output versus either peptide alone, while preserving more physiological pulse architecture than long-acting DAC-modified GHRH analogs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody Composition and Lipolysis\u003c\/strong\u003e — Tesamorelin’s documented effects on visceral adipose tissue are studied alongside Ipamorelin’s anabolic and lipolytic support, with interest in fat-mass reduction and lean-mass preservation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnabolic and Recovery Research\u003c\/strong\u003e — The blend is used in models of sarcopenia, cachexia, connective-tissue injury, and post-catabolic recovery via elevated GH\/IGF-1 signaling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic and Endocrine Modulation\u003c\/strong\u003e — Research explores insulin sensitivity, lipid profiles, and GH-axis restoration in aging or metabolically disrupted models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSelectivity Profile\u003c\/strong\u003e — Ipamorelin’s relatively clean GHS-R1a activity is often chosen to limit cortisol\/prolactin rise compared with older GHRPs, while Tesamorelin supplies the GHRH-side stimulus.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Omni Peptides","offers":[{"title":"13 mg (10+3)","offer_id":51118661042423,"sku":"TI103","price":600.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/tesaipa_13mga.png?v=1788628709","url":"https:\/\/dubaipeptides.ae\/products\/tesa-ipa-blend","provider":"Dubai Peptides","version":"1.0","type":"link"}